@article{TLCR16205,
author = {Feng-Ming (Spring) Kong and Lujun Zhao and Luhua Wang and Yuhchyau Chen and Jie Hu and Xiaolong Fu and Chunxue Bai and Li Wang and Theodore S. Lawrence and Mitchell S. Anscher and Adam Dicker and Paul Okunieff},
title = {Ensuring sample quality for blood biomarker studies in clinical trials: a multicenter international study for plasma and serum sample preparation},
journal = {Translational Lung Cancer Research},
volume = {6},
number = {6},
year = {2017},
keywords = {},
abstract = {Background: Sample quality is critical for biomarker detection in oncology, and platelet degradation and contamination in plasma have a remarkable impact on the ability to accurately quantify many blood-based biomarkers. Platelet factor 4 (PF4) can be used as an indicator to monitor sample quality. This multicenter study aimed to determine the impact of critical components of the blood sample handling process on platelet degradation/contamination and to establish an optimal method for collecting platelet-poor plasma samples.
Methods: At each of six participating centers, blood samples were drawn from 12–13 healthy volunteers. Serum and plasma samples were prepared from whole blood samples using nine different methods that have been commonly used in ongoing multicenter trials. PF4 levels in the prepared samples were measured by enzyme-linked immunosorbent assay (ELISA). Paired t-tests were used for statistical analysis.
Results: Blood samples were collected from 74 subjects enrolled in six centers. PF4 levels were significantly higher in serum samples than in plasma samples (P},
issn = {2226-4477}, url = {https://tlcr.amegroups.org/article/view/16205}
}